IRF4 and B-cell non-Hodgkin lymphoma: In the most recent publication from the World Health Organization (WHO) Classification of Tumours of Haematopoietic and Lymphoid Tissues, one B cell lymphoma entity with interferon regulatory factor (IRF)‐4 rearrangement has been recognized.